GWO, CA39138C1068

Analyst cuts target for Great-West Lifeco stock to CAD 94.00 from CAD 95.00

Published on 10/20/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Great-West Lifeco stock follows second-quarter revenue of CAD 8.35 billion and EPS of CAD 1.16. The results cover the second quarter of 2026.

Company events and dates

  • An analyst cut the target from CAD 95.00 to CAD 94.00 on October 19, 2026.
  • Second-quarter 2026 revenue reached CAD 8.35 billion, while earnings per share were CAD 1.16.
  • Great-West Lifeco stock trades at EUR 57.17 at 11:18 a.m. CEST at Lang & Schwarz on October 20, 2026.
  • The next earnings report is scheduled for November 4, 2026.
GWO, CA39138C1068, Illustration mit AI erstellt.

Great-West Lifeco (ISIN CA39138C1068) faces a lower analyst target of CAD 94.00, down from CAD 95.00, while its second-quarter 2026 revenue reached CAD 8.35 billion. According to The Globe and Mail on October 19, 2026, the analyst kept a sector perform view and reduced the target from CAD 95.00 to CAD 94.00.

What does the target cut change?

The adjustment is modest in absolute terms, but it points to a more cautious near-term view of Great-West Lifeco's operating mix. The Globe and Mail cited rising Canadian group insurance claims, moderating profit growth at Empower Wealth and possible quarterly earnings volatility from the Capital and Risk Solutions repositioning.

The target remains above the latest Toronto quotation. Great-West Lifeco closed at CAD 90.02 on the TSX on October 19, 2026, while its market capitalization stood at CAD 80.6 billion. Its 52-week range was CAD 57.56 to CAD 95.96 on that date.

Three events shape the picture

On July 29, 2026, Great-West Lifeco reported second-quarter revenue of CAD 8.35 billion, up 5.40 percent from the prior-year period, and earnings per share of CAD 1.16, up from CAD 0.96. These figures were reported by Simply Wall St. On October 7, 2026, Barclays raised its target from CAD 87.00 to CAD 91.00, according to Stock Analysis. The October 19 target reduction is the latest of the three dated developments.

When does Great-West report next?

Great-West Lifeco's next earnings report is scheduled for November 4, 2026, according to Simply Wall St. That release will give investors a fresh test of claims trends, Empower's growth and the company's ability to sustain earnings expansion.

Stock price in German trading

Great-West Lifeco stock was trading at EUR 57.17 at Lang & Schwarz on October 20, 2026 at 11:18 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.

Great-West Lifeco market facts

  • Company: Great-West Lifeco Inc.
  • ISIN: CA39138C1068
  • Ticker: GWO
  • Primary exchange: TSX
  • Price Lang & Schwarz (as of October 20, 2026, 11:18 a.m. CEST): EUR 57.17
  • Market capitalization: CAD 80.6 billion (as of October 19, 2026)
  • 52-week range: CAD 57.56-95.96 (as of October 19, 2026)
  • Sector / Industry: Insurance
  • Next earnings date: November 4, 2026

Market context: Market report S&P/TSX Composite.

More news and analyses on Great-West Lifeco stock

Disclaimer...
en | CA39138C1068 | GWO | boerse | 70371634 | bgmi